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Abstract. Here, we present liquid extraction sur-
face analysis (LESA) coupled with electron-
induced dissociation (EID) mass spectrometry in
a Fourier-transform ion cyclotron resonance
mass spectrometer for the analysis of small or-
ganic pharmaceutical compounds directly from
dosed tissue. First , the direct infusion
electrospray ionisation EID and collision-induced
dissociation (CID) behaviour of erlotinib,
moxifloxacin, clozapine and olanzapine stan-
dards were compared. EID mass spectra were also compared with experimental or reference electron impact
ionisation mass spectra. The results show that (with the exception of erlotinib) EID and CID result in comple-
mentary fragment ions. Subsequently, we performed LESA EID MS/MS and LESA CID MS/MS on singly
charged ions of moxifloxacin and erlotinib extracted from a thin tissue section of rat kidney from a cassette-
dosed animal. Both techniques provided structural information, with the majority of peaks observed for the drug
standards also observed for the tissue-extracted species. Overall, these results demonstrate the feasibility of
LESA EID MS/MS of drug compounds from dosed tissue and extend the number of molecular structures for
which EID behaviour has been determined.
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Introduction
Tandem mass spectrometry, in which a precursor ion ischaracterised according to its fragments, is well-
established as a tool for structural elucidation. Although
collision-based methods remain the method of choice for the
most part, there has been a growing reliance on electron-
mediated methods over the past 20 years following the intro-
duction of electron capture dissociation (ECD) [1]. ECD and
the related method of electron transfer dissociation (ETD) [2]
involve the capture/transfer of low-energy electrons by multi-
ply charged cations. Electron-induced dissociation (EID) in-
volves irradiation of singly charged ions with higher energy
electrons causing further ionisation and/or excitation followed
by dissociation of the precursor. EID is used here as a generic
term to include methods which have been previously termed as
electron-induced excitation of ions from organics (EIEIO) [3],
electron excitation dissociation (EED) [3], and electron
ionisation dissociation (also EID) [4]. EID has been applied
to the structural characterisation of peptides [4–8], polyketides
[9], metabolites [10], lipids [11], betaine dimers [12], amino
acids [5], phosphorylated nucleotides [13], glycoconjugates
(including glycopeptides, glycoalkaloids and glycolipids)
[14], oxo-centered trinuclear carboxylate-bridged iron
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complexes [15] and octaethylporphoryin and its iron complex
[16]. Mosely et al. [17] compared the EID mass spectra of 33
small singly charged organic molecules of pharmaceutical
interest with their corresponding collision-induced dissociation
(CID) mass spectra. They found that EID resulted in comple-
mentary fragments to CID, with very little overlap in observed
product ions, suggesting that structural characterisation of such
species would benefit from inclusion of both fragmentation
techniques.
Recent work in our laboratory has focused on in situ anal-
ysis of biomolecules directly from biological substrates by use
of liquid extraction surface analysis (LESA) mass spectrome-
try. LESA [18] has been demonstrated as a useful tool in the
spatial profiling (imaging) of proteins [19, 20], lipids [21], and
small molecule drugs [22, 23] in thin tissue sections. Here, we
present LESA EID mass spectrometry of pharmaceutical com-
pounds from kidney tissue from a cassette-dosed animal. Initial
experiments focused on establishing the EID behaviour of
erlotinib, olanzapine, moxifloxacin and clozapine small
molecule drug standards (see Table 1), and comparing EID
with CID behaviour. EID MS/MS spectra were also compared
with electron impact ionisation mass spectra, either measured
EI mass spectra or that reported in the NIST database (http://
webbook.nist.gov/chemistry) [24–26]. Subsequently, we
performed LESA mass spectrometry on a thin tissue section
of rat kidney cassette-dosed with erlotinib, moxifloxacin,
olanzapine and terfenadine. (The EID behaviour of terfenadine
has previously been reported by Mosely et al. [17]). Peaks
corresponding to singly charged erlotinib and moxifloxacin
were observed in the mass spectrum. EID MS/MS and CID
MS/MSwere performed on singly charged ions of erlotinib and
moxifloxacin. Despite the lower signal-to-noise of the LESA
extracted precursor ions, the results show that structural infor-
mation can be obtained following LESAEID, with the majority
of fragments observed for the standard also observed for the
tissue-extracted species. Nevertheless, the loss of the methyl
ether group, which was unique to EID of the moxifloxacin
standard, was not observed in the tissue-extracted species.
Table 1. Small Molecule Drug Compounds
Small molecule drug compounds Elemental formulae Monoisotopic mass (Da) Medical use
Erlotinib C22H23N3O4 393.16885 Anticancer
Olanzapine C17H20N4S 312.14085 Antipsychotic
Moxifloxacin C21H24FN3O4 401.17507 Antibacterial
Clozapine C18H19N4S 326.12981 Antipsychotic
Figure 1. Erlotinib: (a) EIDmass spectrum; (b) CIDmass spectrum; (c) schematic of bonds cleaved during EID and CID; (d) EI mass
spectrum and (e) schematic of bonds cleaved during EI. Red and blue fragments on the EID and CID spectra highlight the different
relative abundances observed
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Overall, these results show that LESA EID MS/MS of drug
compounds from dosed tissue is feasible, expand the group of
small organic molecules for which EID behaviour has been
determined, and confirm that, in general, EID and CID provide
complementary structural information.
Experimental
Materials
Stock solutions of erlotinib, moxifloxacin, and olanzapine at
10 mM were supplied by AstraZeneca (Cambridge, U.K).
Stock solutions were diluted in methanol, water (50:50) to a
final concentration of ~ 0.1 μM for EID/CID experiments. Ten
microlitres of stock solution of erlotinib and moxifloxacin were
diluted at around ~ 5 μM concentration for EI experiments.
Methanol (LC-MS grade), acetonitrile (LC-MS grade) and
water (LC-MS grade) were purchased from Fisher Scientific
(Leicestershire, U.K.). One milligram of clozapine (VWR In-
ternational Lutterworth, Leicester, U.K.) was dissolved in 1 mL
of acetonitrile, water, 0.1% of formic acid (49.95:49.95:0.1)
and further diluted to ~ 0.1 μM.
Dosing and Scheduling
Kidney tissue from orally dosed adult male Hans Wistar rats
was used as described by Swales et al. [27]. The drugs were
administered as a cassette containing erlotinib, moxifloxacin,
olanzapine and terfenadine (at 10, 25, 10 and 25 mg/kg, re-
spectively) and were supplied by AstraZeneca. The animal was
euthanized 2 h post-dose. All tissue dissection was performed
by trained AstraZeneca staff (project licence 40/3484, proce-
dure number 10). The kidney was snap frozen and kept at − 80
°C until tissue processing. The kidney was cryosectioned into
10 μm sections using a cryostat CM1850 (LeicaMicrosystems,
Wetzlar, Germany) and thaw mounted into glass slides (Fisher
Scientific, Loughborough, UK) for LESA.
Electron-Induced Dissociation/Collision-Induced
Dissociation
Each of the molecules presented in Table 1 were subjected to
individual fragmentation and analysis using a 7 T solariX-XR
(Bruker Daltonics, Bremen, Germany). Each molecule was
ionised using nanospray ionisation (nESI) in positive ion mode
using a capillary voltage of 800 V, with a temperature of 120
°C. Nanospray ionisation was achieved using pulled glass
Figure 2. Olanzapine: (a) EID spectrum (inset: expandedm/z region, vertical expansion ×16); (b) CID spectrum (inset: expandedm/z
region, vertical expansion × 13) and (c) schematic of bonds cleaved during EID and CID. Fragment ion highlighted in blue is unique to
EID
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capillaries (P-97 Flaming/Brown micropipette puller tip Sutter
Instrument Company, Novato, CA, USA) placed in front of the
capillary spray shield. The singly charged species generated by
electrospray were then isolated in the quadrupole (3 m/z isola-
tion width) prior to CID and EID fragmentation. CID experi-
ments were performed in the collision cell using argon as the
collision gas and a voltage in the range 15 to 23 V (depending
on the precursor ion). Three mass spectra were acquired at
different voltages to aid in the identification of fragment ions.
Each mass spectrum comprises 200 co-added scans. EID was
performed in the ion cyclotron resonance cell (ParaCell) [28].
Electrons were supplied by a heated cathode at a current of
1.60 A, a cathode bias of 24.1 V, and lens potential of 0 V. EID
pulse length was varied, according to each precursor ion,
between 0.04 s and 0.06 s. Each EID mass spectrum comprises
800 co-added scans. MS experiments were performed in the
broadband mode (m/z 80–500) with the following settings: 4-
M data size, 1-s ion accumulation time, 0.9-ms time of flight
and sweep width of 14.3 kHz. EID and CID spectra were
externally calibrated with sodium trifluoroacetic acid clusters
(mass accuracy of 5 ppm). EID background spectra were
acquired by leaving all the parameters the same, but with the
capillary spray voltage set to zero. EID background signal was
subtracted from each EID spectra using in-house software.
Only ions with a signal-to-noise ratio above 10 are reported
(Supplementary Tables S-1 to S-8). Data analysis was per-
formed with Data Analysis 4.2 software (Bruker Daltonics),
in-house software, and validated by manual analysis.
Electron Ionisation
Erlotinib and moxifloxacin were ionised using a Waters solids
probe (Waters Corp.,Milford, MA, USA). Samples were left to
dry at ambient temperature on a glass capillary inserted into the
solids probe before it was placed inside the mass spectrometer
Waters GTC Premier micromass (Waters Corp., Milford, MA,
USA). The temperature was gradually increased in 10 K steps
until fragment ions were observed from the molecular ion. Data
acquisition and processing were carried out using MassLynx
(ver. 4.1) software (Waters Corporation,Manchester, UK). The
instrument was calibrated using heptacosafluorotributylamine
to a mass range of m/z 49.996 to m/z 613.694. EI spectra of
Figure 3. Clozapine: (a) EID spectrum (inset: expanded m/z region, vertical expansion × 1200); (b) CID spectrum (inset: expanded
m/z region, vertical expansion × 10) and (c) schematic of bonds cleaved during EID and CID. Fragment ions highlighted in red are
unique to EID, and in blue are unique toCID. Fragment ions shown in green highlight the radical fragmentation of the EID experiments
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olanzapine, and clozapine, were obtained from the NIST
Chemistry WebBook (http://webbook.nist.gov/chemistry) and
manually assigned by the authors.
Liquid Extraction Surface Analysis
LESA of kidney tissue sections was performed by use of a
Triversa NanoMate (Advion Biosciences, Ithaca, NY, USA),
with a nanospray chip with 2.5-um ID nozzles. LESA Points
software (Advion Biosciences, Ithaca, NY, USA) was used to
select the precise location of the tissue to be sampled. The
sample was loaded onto a universal adapter plate and placed
in the Triversa Nanomate. The LESA extraction solvent com-
prised acetonitrile, water, isopropanol and 1% formic acid
(47:47:5:1). Five microlitres of extraction solvent was aspirated
from the solvent well. The robotic arm relocated to a position
above the tissue and descended to a height 0.6 mm above the
surface of the sample. Two microlitres of the solution was
dispensed onto the tissue, forming a liquid microjunction.
The liquid microjunction was maintained for 60 s, with one
mixing step; then 2.5 μL were reaspirated into the pipette tip.
The Triversa Nanomate was coupled with the solariX-XR
(Bruker Daltonics, Bremen, Germany). Samples were
introduced into the mass spectrometer via the Triversa
Nanomate, with gas pressure 0.45 psi, a tip voltage of 2.0 kV
and a capillary temperature of 150 °C. MS experiments were
performed in broadband mode (m/z 80–500) with the following
settings: 512 K data size, 1 s ion accumulation time, 0.9 ms
time of flight and sweep width of 14.3 kHz. The mass spectra
were ca l ibra ted by single-poin t correc t ion wi th
diethyhexylphalate (m/z 391.28429), which has an m/z close
to that of erlotinib (m/z 394.17613) and moxifloxacin (m/z
402.18181). EID and CID parameters were as above with the
exception that CID was performed at a voltage of 18 V only.
Mass spectra comprise 20 co-added scans.
Results and Discussion
Electron ionisation, electron-, and collision-induced
dissociation
Figure 1a, b shows the EID and CID mass spectra obtained
from erlotinib. Similar cleavage was observed for the two
techniques (Fig. 1c and Supplemental Table S-1) therefore
either CID or EID can be used to obtain structural information
for erlotinib. Two of the fragment ions (290.092 m/z and
Figure 4. Moxifloxacin: (a) EID spectrum; (b) CID spectrum; (c) enhancedm/z region (vertical expansion: EID = × 1200, CID = × 40,
respectively), with the fragment ions at three different CID potentials; including EID and EI spectra with the loss of the methyl ether
radical group ([M – ●CH3O]
+); (d) schematic of bonds cleaved during EID and CID. Fragment ion highlighted in red is unique to EID
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292.108 m/z) show different relative abundances by EID and
CID. [C17H14N3O2]
+ (290.092m/z, shown in blue in Fig. 1a, b)
is less abundant following CID compared to EID, whereas
[C17H14N3O2]
+ (292.108 m/z, shown in red in Fig. 1a, b), is
more abundant following CID than EID. Nevertheless, there is
no apparent advantage, in terms of structural confirmation of
erlotinib, of one fragmentation type over the other. Electron
impact ionisation of erlotinib (Fig. 1d) results in a similar
Figure 5. LESA coupled with EID (a) ~ 1 mm2 area sampled from rat kidney tissue mounted in glass slides (animal was dosed with
erlotinib, moxifloxacin, terfenadine and clozapine); (b) MS spectrum of the sampled area; (c) enhanced area of the MS spectrum (2 ×
10); (d) erlotinib: quadrupole isolation spectrum; (e) EID spectrum from erlotinib standard; (f) EID spectrum of erlotinib extracted from
tissue; (g) schematic of bonds cleaved during EID of erlotinib extracted from tissue; (h) moxifloxacin quadrupole isolation spectrum;
(i) EID spectrum from moxifloxacin standard; (j) EID spectrum of moxifloxacin extracted from the tissue; (k) schematic of bonds
cleaved during EID of moxifloxacin extracted from tissue
Table 2. LESA EID of Erlotinib and Moxifloxacin Fragment ions Observed in Kidney Tissue
Small molecule Theoretical (m/z) Experimentala (m/z) Assignment Error (external calibration, ppm) Error (internal calibration, ppm)
Erlotinib 394.17613 394.17602 [C22H23N3O4+H]
+ − 3.62 − 0.28
336.13426 336.13449 [C19H18N3O3]
+ − 3.57 0.68
304.10805 304.10797 [C18H14N3O2]
+ − 2.94 − 0.26
290.09239 290.09228 [C17H12N3O2]
+ − 3.60 − 0.38
278.09240 278.09232 [C16H12N3O2]
+ − 3.25 − 0.29
260.08183 260.08191 [C16H10N3O]
+ − 4.03 0.31
250.09478 250.09520 [C15H13N3O2]
+ − 3.28 1.27
Moxifloxacin 402.18235 402.18238 [C21H24FN3O4+H]
+ − 3.83 0.07
384.17189 384.17243 [C21H23FN3O3]
+ − 4.08 1.40
364.16566 364.16546 [C21H22N3O3]
+ − 4.20 − 0.54
358.19252 358.19269 [C20H25FN3O2]
+ − 3.78 0.47
338.18630 338.18591 [C20H24N3O2]
+ − 3.68 − 1.15
261.10337 261.10362 [C14H15FN2O2]
+ − 3.46 0.95
aExperimental m/z reported was obtained after internal calibration
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cleavage to both EID MS/MS and CID MS/MS (Fig. 1e and
Supplemental Table S-2).
EID and CID mass spectra obtained from olanzapine are
shown in Fig. 2a, b. Again, similar fragmentation patterns are
observed for the two techniques (Fig. 2c and Supplemental
Table S-3). The only additional fragment observed following
EID is the ion [C13H12N3S]
+. The EI mass spectrum for
olanzapine (obtained from the NIST Chemistry WebBook,
Supplementary Fig. S-4) is similar to the EID MS/MS spec-
trum, including the observation of the [C13H12N3S]
+ fragment,
although in the case of EI that fragment corresponds to the base
peak in the mass spectrum.
Figure 3a shows the EID and CID mass spectra obtained
from clozapine. The fragments observed are detailed in
Supplementary Table S-5. Three fragment ions were ob-
served following EID that were not observed following
CID (highlighted in red in Fig. 3a). One fragment ion was
observed in the CID spectrum of clozapine, corresponding
to [C16H12ClN3]
+ (highlighted in blue in Fig. 3b) which
was not observed in the EID mass spectrum. Fragment ions
shown in green (Fig. 3) correspond to the cleavage of the
same bond in the methylpiperazine moiety and highlights
the radical fragmentation of the EID experiments compared
to CID (Fig. 3c). The overall bond cleavage obtained by
EID and CID is similar to that observed in the EI mass
spectrum of clozapine shown in the Supplemental Fig. S-6.
(Abundant low m/z fragment ions observed following EI,
but not EID or CID, are shown in red).
Figure 4a, b shows the EID and CID mass spectra obtained
frommoxifloxacin. The fragments observed are summarised in
Supplemental Table S-7. Five fragment ions are common to
both, mostly losses of functional groups around the core struc-
ture, for instance loss of water, carbon dioxide and hydrogen
fluoride. There is a fragment ion at m/z 371.16220 (loss of
●CH3O from the precursor ion) which is observed in the EID
mass spectrum but not the CID mass spectrum, highlighted red
in Fig. 4a. Figure 4c shows an expanded m/z region from the
CID mass spectra (obtained with different collision voltages),
EID mass spectrum and EI mass spectrum. (The full EI mass
spectrum is shown in Supplemental Fig. S-8 and assignment of
the fragment ions is presented in Supplemental Table S-9).
Loss of the radical methyl ether moiety is observed only in
the EID and EI mass spectra of moxifloxacin.
The results described above suggest that, in most cases,
complementary fragments are observed following CID and
EID of these small molecule drug compounds. These findings
support earlier work by Mosely et al. [17] and suggest that
structural elucidation of small singly charged molecules will
benefit from inclusion of both fragmentation approaches. The
EID fragmentation efficiency, calculated as the sum of the
intensities of the fragment ions (excluding the precursor ion
and the charge-reduced species) divided by the total ion abun-
dance in the EID spectrum [29], is low for all the drug com-
pounds when compared to CID fragmentation (see Supplemen-
tary Table S-10). This finding is in agreement with Prakash
et al. [30].
LESA EID/CID
Following the experiments on small molecule drug standards,
we subsequently applied EID and CID MS/MS to pharmaceu-
tical compounds sampled directly from drug-dosed tissues by
LESA. Figure 5a shows a photograph of a thin tissue section of
kidney, from an animal dosed with erlotonib, moxifloxacin,
olanzapine and terfenadine, mounted on a glass slide. The
corresponding LESA mass spectrum of the sampled area is
shown in Fig. 5b. The expanded m/z region (m/z 393–404)
(Fig. 5c) reveals the presence of peaks at m/z 394.17543 and
m/z 402.18632, corresponding to the singly charged ions of
erlotinib (Δ 1.77 ppm) and moxifloxacin (Δ 2.36 ppm), respec-
tively. Peaks corresponding to olanzapine and terfenadine or
their metabolites were not observed. (In previous work, these
species were observed following LESA [27]; however, that
work was performed on a Q-trap instrument offering higher
sensitivity than the FT-ICR). Figure 5d shows the mass spec-
trum obtained following quadrupole isolation of m/z 394
Table 3. LESA CID of Erlotinib and Moxifloxacin Fragment ions Observed in Kidney Tissue
Small molecule Theoretical (m/z) Experimentala (m/z) Assignment Error (external calibration, ppm) Error (internal calibration, ppm)
Erlotinib 394.17613 394.17591 [C22H23N3O4+H]
+ − 0.80 − 0.05
336.13426 336.13430 [C19H18N3O3]
+ − 1.07 0.11
304.10805 304.10780 [C18H14N3O2]
+ − 1.04 0.19
290.09239 290.09228 [C17H12N3O2]
+ − 1.36 − 0.35
292.10805 292.10801 [C17H14N3O2]
+ − 0.94 − 0.13
278.09240 278.09243 [C16H12N3O2]
+ − 1.10 0.12
260.08183 260.08189 [C16H10N3O]
+ − 1.04 0.11
250.09478 250.09750 [C15H13N3O2]
+ − 1.04 0.87
248.08183 248.08182 [C15H10N3O2]
+ − 0.56 − 0.05
Moxifloxacin 402.18235 402.18206 [C21H24FN3O4+H]
+ − 0.03 − 0.73
384.17189 384.17226 [C21H23FN3O3]
+ 1.56 0.97
358.19252 358.19238 [C20H25FN3O2]
+ 0.02 − 0.40
338.18630 338.18620 [C20H24N3O2]
+ 0.93 − 0.28
261.10337 261.10339 [C14H15FN2O2]
+ − 0.03 0.07
220.06425 220.02624 [C11H9FN2O2]
+ − 0.04 − 0.04
aExperimental m/z reported was obtained after internal calibration
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(erlotinib), and Fig. 5e shows the same for m/z 402
(moxifloxacin). These isolated ions were fragmented by EID
(Fig. 5f, j) and the results are summarised in Table 2. Six
fragment ions were identified in the EID spectrum of erlotinib
and five fragment ions were present in the EID spectrum of
moxifloxacin. In contrast to the EID of the moxifloxacin stan-
dard, loss of the radical methyl ether moiety was not observed
in the EID of the moxifloxacin extracted directly from the
tissue. This observation is likely due to the low extraction
efficiency of the LESA experiment, which did not provide
sufficient signal-to-noise ratio for the radical fragment ion to
be detected. Surprisingly, sufficient erlotinib and moxifloxacin
were extracted from the tissue in a single sampling event to
acquire 20 scans of CID followed by EID for both drug
molecules, i.e., we were able to compare EID and CID frag-
mentation from the same sampling location (see Supplemental
Fig. S-11).
Table 3 shows the fragment ions observed following CID of
singly charged erlotonib and moxifloxacin. A total of 89% of
the fragment ions observed in the CID mass spectrum of
erlotinib standard (Supplemental Table S-1) were also identi-
fied in the LESACID of erlotonib in tissue, whereas 71% of the
fragment ions observed for moxifloxacin standard were present
in the LESA CID mass spectrum of moxifloxacin.
Conclusions
The EID fragmentation behaviour of singly charged ions of
erlotinib, moxifloxacin, clozapine and olanzapine has been
determined. With the exception of erlotinib, EID MS/MS
results in complementary fragments when compared with
those observed following CID MS/MS. Our findings sup-
port the earlier work of Mosely et al. [17], i.e. that greater
structural information about small organic molecules of
pharmaceutical interest can be obtained through inclusion
of both techniques in their analysis. Moreover, we demon-
strate the feasibility of LESA EID MS/MS of drug com-
pounds extracted directly from dosed tissue. Despite the
lower S/N of the tissue-extracted drugs, a natural conse-
quence of the use of tissue from dosed animals coupled
with LESA extraction efficiency, the results show that the
majority of fragments observed for the drug standards are
also observed from tissue.
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